Hints and tips:
...Most of the activity has been in the US, including last week’s $25bn acquisition of New York-based Forest Laboratories by Actavis, one of the world’s biggest generic drugmakers....
...United States v Apple, Inc et al is more than a US Justice department antitrust action against publishers allegedly colluding on ebook prices....
...This will be like therapy for us: therapy with the FT. Except I think I won’t get pancakes this time....
...Elsewhere in the sector, Forest Laboratories added 4.8 per cent to $34.74 and Watson Pharmaceutical rose 2.2 per cent to $63.36. The S&P healthcare index put on 1 per cent....
...And why, now, doesn’t someone come along and eat Durant for lunch, in the way that Blockbuster has been laid low by Netflix et al? There are two answers (at least)....
International Edition